Fabrication, falsification and plagiarism in biotech

Introduction

Fabrication, falsification and plagiarism (FFP) are three major forms of research misconduct that threaten the credibility, reliability and ethical integrity of biotechnology research. Biotechnology involves scientific activities relating to genetic engineering, molecular biology, genomics, synthetic biology, stem-cell research, pharmaceutical development and other biological innovations. Research in these areas often influences medical treatments, public health policies, agricultural development and environmental protection. Therefore, scientific accuracy and research integrity are essential.

Fabrication refers to inventing research data or experimental results that were never obtained. Falsification involves manipulating research materials, processes, data or results to create misleading scientific conclusions. Plagiarism occurs when researchers use another person's ideas, research findings, text or intellectual contributions without appropriate acknowledgement.

These practices can lead to incorrect scientific conclusions, unsafe medical products, ineffective treatments, financial losses and damage to public confidence in scientific institutions. Consequently, biotechnology research requires strong ethical standards, institutional supervision, transparent documentation and effective legal mechanisms to prevent research misconduct.

Meaning and nature of fabrication, falsification and plagiarism

1. Fabrication

Fabrication means creating false research information, experimental observations or scientific results and presenting them as genuine findings.

In biotechnology, fabrication may include:

Inventing DNA sequencing results without conducting the experiment.

Creating false laboratory observations in genetic engineering research.

Reporting experiments involving microorganisms that were never performed.

Inventing clinical trial participants or biological sample results.

Creating imaginary data concerning the effectiveness of genetically modified organisms.

Fabrication undermines the scientific process because subsequent researchers may rely on results that have no factual foundation.

2. Falsification

Falsification involves manipulating research materials, equipment, processes or scientific information so that research findings are inaccurately represented.

Examples include:

Altering genetic sequencing results to support a predetermined hypothesis.

Manipulating laboratory images or microscopy photographs.

Removing experimental observations that contradict the researcher's conclusions without scientific justification.

Changing biological sample measurements.

Misrepresenting the results of biotechnology experiments.

Unlike fabrication, falsification generally involves manipulating existing research material or information rather than inventing the entire underlying data.

3. Plagiarism

Plagiarism occurs when a researcher presents another person's scientific work, ideas, data, research methodology or written material as their own without proper acknowledgement.

In biotechnology, plagiarism may involve copying genetic research findings, experimental designs, scientific publications, laboratory protocols or computational research without appropriate attribution.

It also includes certain forms of self-plagiarism, where researchers reuse previously published material without appropriate disclosure or acknowledgement, particularly when this creates a misleading impression of original research.

Legal and regulatory framework in India

1. University Grants Commission (Promotion of Academic Integrity and Prevention of Plagiarism in Higher Educational Institutions) Regulations, 2018

These regulations establish standards for academic integrity and plagiarism prevention in higher educational institutions.

They provide mechanisms for identifying plagiarism, conducting investigations and imposing academic consequences.

The regulations classify plagiarism according to similarity levels:

Level 0: Up to 10% similarity.

Level 1: Above 10% to 40%.

Level 2: Above 40% to 60%.

Level 3: Above 60%.

The prescribed consequences vary according to the seriousness and nature of plagiarism.

These regulations are particularly relevant to biotechnology researchers working in universities, postgraduate institutions and academic research laboratories.

2. Indian Council of Medical Research (ICMR) Guidelines

The ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017 establish ethical principles for biomedical research involving human participants.

They emphasise scientific integrity, responsible research conduct, transparency, informed consent and institutional ethical oversight.

Fabricating or falsifying research results may undermine these principles and compromise the safety and rights of research participants.

3. Drugs and Cosmetics Act, 1940

The Drugs and Cosmetics Act, 1940 regulates the manufacture, import and distribution of drugs and applicable medical products in India.

Fabricated or falsified scientific information submitted to support the safety, quality or effectiveness of pharmaceutical and biotechnology products may attract regulatory consequences under applicable provisions.

4. New Drugs and Clinical Trials Rules, 2019

These rules regulate clinical trials and related activities involving new drugs in India.

They establish requirements concerning informed consent, ethics committee approval, clinical trial registration, safety reporting and compensation for trial-related injury or death.

Manipulation or fabrication of clinical trial data can compromise regulatory decision-making and patient safety.

5. Bharatiya Nyaya Sanhita, 2023

The Bharatiya Nyaya Sanhita, 2023 may become relevant where research misconduct involves independent criminal conduct, such as cheating, forgery or falsification of documents.

Depending on the facts, Sections 318 and 336 concerning cheating and forgery may become relevant. However, ordinary research misconduct does not automatically constitute a criminal offence.

Major forms of research misconduct in biotechnology

1. Manipulation of genetic research data

Genetic research depends on accurate sequencing, gene expression measurements and molecular analysis. Altering such results can create false scientific conclusions and mislead other researchers.

2. Misrepresentation of clinical trial findings

Biotechnology companies may conduct clinical studies to establish the safety and effectiveness of gene therapies, vaccines and biological medicines. Concealing adverse findings or inventing favourable results can threaten patient safety.

3. Plagiarism in genomic research

Researchers may copy genetic research interpretations, computational methods or scientific publications without acknowledging the original authors.

4. Manipulation of laboratory images

Microscopy images, electrophoresis results and experimental photographs are important forms of scientific evidence. Improper alteration may misrepresent the actual experimental findings.

5. Misuse of biotechnology research publications

Researchers may publish substantially overlapping studies, manipulate authorship contributions or selectively report experimental findings to improve academic recognition.

Important case laws and judicial decisions

1. Association for Molecular Pathology v. Myriad Genetics, Inc. (2013)

The United States Supreme Court examined the patent eligibility of isolated human DNA and complementary DNA (cDNA).

The Court held that naturally occurring DNA sequences are not patent-eligible merely because they have been isolated, while cDNA may qualify for patent protection in the circumstances discussed in the judgment.

Relevance: Although this was not a research-misconduct case, it demonstrates the importance of scientific accuracy, transparency and proper representation of biological discoveries in biotechnology-related legal proceedings.

2. Daubert v. Merrell Dow Pharmaceuticals, Inc. (1993)

The United States Supreme Court examined the admissibility of scientific expert evidence.

The Court emphasised that scientific evidence must be relevant and reliable. Factors such as testability, peer review, known error rates and general acceptance may assist courts in evaluating scientific evidence.

Relevance: This judgment is important for biotechnology because courts may need to assess the reliability of genetic testing, laboratory findings and scientific research presented as evidence.

3. United States v. Harkonen (2013)

The case involved the use of misleading statements concerning clinical trial results in promoting a pharmaceutical product.

The prosecution concerned fraudulent representations about the interpretation and significance of clinical research findings.

Relevance: The case illustrates how misleading scientific representations may result in serious legal consequences, particularly where clinical research is used to influence medical and commercial decisions.

4. Office of Research Integrity proceedings concerning Dr. Anil Potti

Dr. Anil Potti, associated with cancer research at Duke University, became involved in a major research-integrity controversy concerning genomic prediction models.

Investigations identified serious concerns regarding the reliability and integrity of published research, resulting in retractions and institutional consequences.

Relevance: This controversy demonstrates how unreliable genomic data and questionable analytical practices can affect cancer research, clinical decision-making and public confidence in biotechnology.

5. Hwang Woo-suk stem-cell research controversy (2005–2006)

South Korean researcher Hwang Woo-suk became involved in a major scientific misconduct controversy concerning claims of producing patient-specific human embryonic stem-cell lines.

Investigations established that important reported research findings had been fabricated.

The controversy resulted in scientific retractions and significant institutional and reputational consequences.

Relevance: This is one of the most significant examples of fabrication in biotechnology. It demonstrates how false scientific findings can damage public confidence, waste research resources and undermine the credibility of stem-cell research.

Consequences of fabrication, falsification and plagiarism

Research misconduct in biotechnology can produce serious consequences for individuals, institutions and society.

1. Scientific consequences

False research findings may mislead future studies, distort scientific knowledge and create unreliable research databases.

2. Medical consequences

Fabricated clinical findings may influence the development or approval of unsafe or ineffective treatments, potentially placing patients at risk.

3. Legal consequences

Researchers may face disciplinary proceedings, contractual liability, regulatory action or criminal prosecution where the misconduct also satisfies the requirements of an applicable offence.

4. Institutional consequences

Universities, biotechnology companies and research laboratories may suffer reputational damage, loss of funding and reduced public confidence.

5. Intellectual property consequences

Plagiarism and misappropriation of research may create disputes involving copyright, patent ownership, authorship and commercial exploitation.

Prevention and institutional accountability

Biotechnology institutions should establish comprehensive research-integrity systems to prevent fabrication, falsification and plagiarism.

Important preventive measures include:

Maintaining original laboratory notebooks and research records.

Preserving raw sequencing data and experimental observations.

Conducting independent verification of important research findings.

Using plagiarism-detection and image-integrity assessment systems.

Establishing institutional research-integrity committees.

Ensuring transparent authorship and contribution declarations.

Providing regular training in research ethics.

Establishing confidential reporting and whistleblower protection mechanisms.

Correcting or retracting unreliable scientific publications.

Conducting independent audits of research data and laboratory procedures.

Institutions should also distinguish between deliberate misconduct, honest scientific errors and reasonable differences in scientific interpretation. Appropriate investigations must consider evidence, intent and the seriousness of the alleged violation.

Conclusion

Fabrication, falsification and plagiarism represent serious threats to the integrity of biotechnology research. These practices undermine scientific reliability, compromise medical safety, damage institutional credibility and weaken public confidence in scientific innovation.

In India, research integrity is supported by the UGC Regulations, 2018, ICMR ethical guidelines, clinical trial regulations and applicable criminal and intellectual property laws. Judicial decisions such as Daubert v. Merrell Dow Pharmaceuticals provide important principles for evaluating scientific reliability, while the Hwang Woo-suk controversy and Dr. Anil Potti proceedings demonstrate the consequences of research misconduct in modern biotechnology.

Ultimately, preventing research misconduct requires transparent scientific practices, independent institutional oversight, responsible publication standards and effective legal accountability. These safeguards are essential for ensuring that biotechnology advances remain scientifically credible, ethically responsible and beneficial to society.